Translational/Early Clinical

The move from bench to clinic requires rigorous testing with high confidence in the results. REALM Pharma Services has the expertise to design and execute targeted studies in Phase 0, I and II, to confirm drug activity and evaluate early treatment response evidence, while reducing risk for later phases. Our solutions provide quantitative, high-quality data to support your research.